|
 |
 |
 |
 |
|
|
|
|
 |
|
 |
|
 |
Zyprexa & Diabetes
Do you have a Zyprexa diabetes case?
In 2002, researchers found metabolic abnormalities ranging from mild blood
sugar problems to diabetic ketoacidosis and coma in patients who had
been prescribed olanzapine, most of whom were otherwise not known to
be diabetic. Diabetic ketoacidosis (DKA) is a serious condition in
which a person experiences an extreme rise in blood glucose level
coupled with a severe lack of insulin, which results in symptoms such
as nausea, vomiting, stomach pain and rapid breathing. Untreated, DKA
can lead to coma and even death.
Don't delay in
learning more
about the settlement of many Zyprexa diabetic and coma cases. It is important to make your claim in a timely manner.
Lawyers agreed to an early settlement with Eli Lilly and Co. on 8,000
claims of damages over the company's top-selling drug Zyprexa.
A $690 million settlement was announced June 9, 2005 after only five plaintiffs had given depositions in the mass litigation and before any substantive depositions had been taken from Lilly executives or scientists.
|
 |
|
 |
 |
 |
|
|
Coma - Diabetic - Zyprexa
|
The Zyprexa coma link and diabetic link is not new. In July 2002, research from Duke University Medical Center suggested a link between Zyprexa and the onset of diabetes. Zyprexa is used to treat a disease widely recognized
as one of the leading causes of death and disability in the U.S.
The drug, olanzapine (trade name Zyprexa), belongs to a relatively new
family of medications called atypical antipsychotics, which are used
to treat schizophrenia, paranoia and manic-depressive disorders. Other
drugs in this class include clozapine, risperidone, quetiapine and
ziprasidone.
|
|
Law Offices of Michael Monheit 1368 Barrowdale Road Rydal, PA 19046
Call Us Toll Free: 866-761-1385 P: 215-840-6573 E: Michael@Monheit.com
|
|
